METACARE CO., Ltd. (KRX:118000)
223.00
0.00 (0.00%)
At close: Apr 8, 2026
METACARE CO. Revenue
In the year 2025, METACARE CO. had annual revenue of 32.82B KRW with 62.42% growth. METACARE CO. had revenue of 10.31B in the quarter ending December 31, 2025, with 84.33% growth.
Revenue
32.82B
Revenue Growth
+62.42%
P/S Ratio
1.17
Revenue / Employee
1.06B
Employees
31
Market Cap
38.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.82B | 12.61B | 62.42% |
| Dec 31, 2024 | 20.21B | 2.95B | 17.10% |
| Dec 31, 2023 | 17.26B | -1.84B | -9.64% |
| Dec 31, 2022 | 19.10B | 484.98M | 2.61% |
| Dec 31, 2021 | 18.61B | 11.99B | 181.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4.56T |
| Celltrion | 4.16T |
| Sam Chun Dang Pharm. | 231.81B |
| ALTEOGEN | 215.86B |
| BCWORLD PHARM. | 75.80B |
| Aprogen Biologics | 73.23B |
| Tdspharm | 27.62B |
| HASS Corp. | 16.59B |